RaySearch and Eckert & Ziegler BEBIG Enter Into Partnership Regarding Brachytherapy
STOCKHOLM, June 3, 2018 /PRNewswire/ -- RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare* oncology information system will be integrated* with the Eckert & Ziegler BEBIG brachytherapy systems.
This will allow Eckert & Ziegler BEBIG to offer a complete brachytherapy solution, including treatment devices, treatment planning and oncology information management. The cooperation is in line with RaySearch's aim to support as many treatment systems and approaches as possible.
Brachytherapy is a radiation therapy technique in which a small radioactive implant is inserted into the patient's tissue, directly into the tumor or close to it. The implant may be temporary or permanent. Using implants makes it possible to deliver a higher dose of radiation to a smaller area than may possible with other forms of radiation therapy, thus minimizing damage to surrounding tissue and organs. Brachytherapy is most commonly used in treating prostate cancer but can be applied to many other areas, including cancers of the brain, eye, lung and skin.
Dr. Harald Hasselmann, CEO of Eckert & Ziegler BEBIG, says: "We are very happy about the partnership with RaySearch, which promises a pathway to better integration of brachytherapy into modern radiation therapy workflows. Brachytherapy can significantly improve treatment outcome, either as a single treatment method or in combination with other therapies. Integration is key for future optimization, and this partnership is an important step forward."
Johan Löf, CEO of RaySearch, says: "It is exciting to enter into this new treatment area for RayStation and RayCare. Brachytherapy is a highly accurate technique, and the capabilities of our software will bring a new dimension to treatment. We have an excellent partner in Eckert & Ziegler BEBIG, a leading brachytherapy innovator with an excellent product portfolio, and I look forward to a successful collaboration."
About Eckert & Ziegler BEBIG
Eckert & Ziegler BEBIG is a global provider of radiotherapy products and a brachytherapy leader in Europe. The company has offices and subsidiaries are located in Belgium, Germany, France, Spain, UK, US, India and Brazil, as well as a worldwide network of distributors and agents. Eckert & Ziegler BEBIG is a young, dynamically growing company and employs approximately 145 people worldwide. The company has been listed on the Euronext stock exchange since April 1997.
RayStation integrates all RaySearch's advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch's market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch's software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
To learn more about RaySearch, go to: www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
President and CEO,
RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510-530-00
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
http://mb.cision.com/Main/1102/2566356/872050.pdf PDF http://news.cision.com/raysearch-laboratories/i/eckert-ziegler-linkedin-pressrelease-rsl- Eckert-Ziegler-LinkedIn- bg-283x142px,c2446003 PressRelease RSL-bg 283x142px
SOURCE RaySearch Laboratories